JIDEYTRO
- Product NDC
- 85001-101
- Requested package NDC
- 85001-101-01
- 11-digit product format
- 850010101
- Labeler code
- 85001
- Product ID
- 85001-101_6c672099-2978-474e-b783-973fe94efcfb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- zidesamtinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Nuvalent, Inc.
- Application
- NDA220185
- Marketing category
- NDA
- Marketing start
- 2026-07-22
- Substance
- ZIDESAMTINIB
- Active strength
- 25 mg/1
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- JIDEYTRO
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ZIDESAMTINIB | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| MX5KQV5XHC | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3760e421-b523-4d9b-e063-6394a90ab94b | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JIDEYTRO | ZIDESAMTINIB | Nuvalent, Inc. | 3760e421-b523-4d9b-e063-6394a90ab94b | 2026-07-22 | Warnings, Adverse reactions | 220185 NDA220185 85001-101-01 85001-101 85001010101 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 85001-101-01 | 85001010101 | 1 BOTTLE in 1 CARTON (85001-101-01) / 30 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2026-07-22 | 0 | Current |